Testing the effects of the GLP-1 receptor agonist exenatide on cocaine self-administration and subjective responses in humans with cocaine use disorder
Gustavo A. Angarita, David Matuskey, Brian Pittman, Jessica Costeines, Marc N. Potenza, Ania M. Jastreboff, Heath D. Schmidt, Robert T. Malison
Topics & Concepts
ExenatideAgonistSelf-administrationGlucagon-like peptide 1 receptorPharmacologyMedicineAddictionPsychologyReceptorEndocrinologyInternal medicineNeuroscienceDiabetes mellitusType 2 diabetesDiabetes Treatment and ManagementNeurotransmitter Receptor Influence on BehaviorNeuropeptides and Animal Physiology